X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS AJANTA PHARMA DR. DATSONS LABS/
AJANTA PHARMA
 
P/E (TTM) x -10.9 20.7 - View Chart
P/BV x 0.2 8.9 1.8% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   AJANTA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
AJANTA PHARMA
Mar-16
DR. DATSONS LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,720 7.3%   
Low Rs311,103 2.8%   
Sales per share (Unadj.) Rs133.0194.6 68.3%  
Earnings per share (Unadj.) Rs0.245.2 0.3%  
Cash flow per share (Unadj.) Rs6.650.3 13.1%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.8132.0 97.5%  
Shares outstanding (eoy) m31.6688.77 35.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.67.3 8.1%   
Avg P/E ratio x516.131.2 1,653.5%  
P/CF ratio (eoy) x11.828.1 42.2%  
Price / Book Value ratio x0.610.7 5.7%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m2,477125,299 2.0%   
No. of employees `000NANA-   
Total wages/salary Rs m562,570 2.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21117,275 24.4%  
Other income Rs m79166 47.3%   
Total revenues Rs m4,28917,442 24.6%   
Gross profit Rs m5695,807 9.8%  
Depreciation Rs m204451 45.4%   
Interest Rs m43049 879.8%   
Profit before tax Rs m135,474 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,460 0.4%   
Profit after tax Rs m54,014 0.1%  
Gross profit margin %13.533.6 40.2%  
Effective tax rate %48.026.7 180.1%   
Net profit margin %0.123.2 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,8527,639 89.7%   
Current liabilities Rs m6,7112,715 247.2%   
Net working cap to sales %3.328.5 11.7%  
Current ratio x1.02.8 36.3%  
Inventory Days Days16143 372.1%  
Debtors Days Days31879 404.8%  
Net fixed assets Rs m3,6736,914 53.1%   
Share capital Rs m317177 179.0%   
"Free" reserves Rs m3,76111,442 32.9%   
Net worth Rs m4,07811,721 34.8%   
Long term debt Rs m1,671149 1,123.6%   
Total assets Rs m12,63314,814 85.3%  
Interest coverage x1.0112.9 0.9%   
Debt to equity ratio x0.40 3,229.8%  
Sales to assets ratio x0.31.2 28.6%   
Return on assets %3.427.4 12.6%  
Return on equity %0.134.2 0.3%  
Return on capital %7.746.5 16.5%  
Exports to sales %22.955.1 41.5%   
Imports to sales %14.36.0 238.0%   
Exports (fob) Rs m9649,527 10.1%   
Imports (cif) Rs m6021,038 58.0%   
Fx inflow Rs m96410,422 9.2%   
Fx outflow Rs m6071,678 36.2%   
Net fx Rs m3578,744 4.1%   
CASH FLOW
From Operations Rs m1,3453,264 41.2%  
From Investments Rs m-2,256-2,093 107.8%  
From Financial Activity Rs m-1,200-1,186 101.2%  
Net Cashflow Rs m-2,111-15 14,261.5%  

Share Holding

Indian Promoters % 4.5 73.8 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 1.4 7.6 17.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.0 553.5%  
Shareholders   20,807 20,968 99.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS